International Journal of Molecular Sciences, Journal Year: 2024, Volume and Issue: 25(24), P. 13691 - 13691
Published: Dec. 21, 2024
Matrix metalloproteinase-2 (MMP-2), a zinc-dependent enzyme, plays critical role in the degradation and remodeling of extracellular matrix (ECM). As member gelatinase subgroup metalloproteinases, MMP-2 is involved variety physiological processes, including tissue repair, wound healing, angiogenesis, embryogenesis. It primarily responsible for type IV V collagen, fibronectin, laminin, elastin, which are essential components ECM. secreted as an inactive pro-enzyme (proMMP-2) activated through proteolytic cleavage, with its activity being precisely regulated by inhibitors metalloproteinases (TIMPs). Dysregulation has been linked to pathological conditions, cardiovascular diseases, diabetic complications, kidney cancer. In it contributes vascular remodeling, atherosclerosis, aneurysms, while fibrotic mediates excessive ECM leading scarring. diabetes, elevated exacerbates complications such nephropathy, retinopathy, disease. cancer, facilitates tumor invasion metastasis degrading promoting angiogenesis. Despite roles both targeting therapeutic purposes presents challenges due dual functions raising concerns about unplanned consequences impaired healing or damage. These underscore need future research focus on developing selective modulators that can balance their under specific disease environments. Clinical trials modulation highlight potential inhibitors, those MMP-2, reduce progression fibrosarcoma, breast, lung cancers. This paper reviews structure, function, regulation involvement pathogenesis, implications modulating activity.
Language: Английский